Cargando…

Disability weights for castration-resistant prostate cancer: an empirical investigation

INTRODUCTION: Health state valuation and diagnostic-therapeutic pathways at the junction between non-metastatic and metastatic castration-resistant prostate cancer (CRPC) are not well documented. We aimed at: (i) estimating the disability weights (DWs) for health states across a continuum of disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borsoi, Ludovica, Ciani, Oriana, Vivo, Rocco De, Russo, Giorgio Ivan, Scarcia, Marcello, De Fino, Chiara, Beccaglia, Patrizia, Luccarini, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AboutScience 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668063/ https://www.ncbi.nlm.nih.gov/pubmed/36628321 http://dx.doi.org/10.33393/grhta.2022.2431

Ejemplares similares

Empirical Support for Optimal Virulence in a Castrating Parasite
por: Jensen, Knut Helge, et al.
Publicado: (2006)

Correction: Empirical Support for Optimal Virulence in a Castrating Parasite
por: Jensen, Knut Helge, et al.
Publicado: (2009)

SCL-90 empirical factors predict post-surgery weight loss in bariatric patients over longer time periods
por: Albert, Umberto, et al.
Publicado: (2022)

First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry
por: Galli, Luca, et al.
Publicado: (2022)

Treatment effect bias in randomised controlled trials using surrogate outcomes: a preliminary cohort study analysis
por: Ciani, Oriana, et al.
Publicado: (2011)

The role of health technology assessment bodies in shaping drug development
por: Ciani, Oriana, et al.
Publicado: (2014)

Editorial: Near-infrared fluorescence guided surgery: State of the evidence from a health technology assessment perspective
por: Bertolaccini, Luca, et al.
Publicado: (2023)

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
por: Tucci, Marcello, et al.
Publicado: (2018)

Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis
por: Borsoi, Ludovica, et al.
Publicado: (2023)

Cross-national agreement on disability weights: the European Disability Weights Project
por: Schwarzinger, Michaël, et al.
Publicado: (2003)

Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study
por: Procopio, Giuseppe, et al.
Publicado: (2020)

Pig castration: will the EU manage to ban pig castration by 2018?
por: De Briyne, Nancy, et al.
Publicado: (2016)

Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia
por: Meregaglia, Michela, et al.
Publicado: (2017)

Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter “real life” study
por: Cindolo, Luca, et al.
Publicado: (2017)

Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence
por: Ciani, Oriana, et al.
Publicado: (2022)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

Implementing shared decision-making interventions in breast cancer clinical practice: a scoping review
por: Oprea, Natalia, et al.
Publicado: (2023)

Comment on The Unbearable Lightness of Difference Between Statistical and Clinical Significance
por: Bertolaccini, Luca, et al.
Publicado: (2022)

People with disability and the COVID-19 pandemic: The need for empiric research
por: Turk, Margaret A., et al.
Publicado: (2021)

Spirituality and Caregiver Burden of People with Intellectual Disabilities: an Empirical Study
por: Xavier, Fabiana Torres, et al.
Publicado: (2023)

Neonatal–Maternal Bodyweight Ratio at Birth: An Indicator for First-Week Survival Prognosis in Canine Newborns
por: Alonge, Salvatore, et al.
Publicado: (2023)

Patient-Reported Outcome Measures in Oncology Drugs Approved by the European Medicines Agency, 2017-2021
por: Ciani, Oriana, et al.
Publicado: (2023)

A call for better reporting of trials using surrogate primary endpoints
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Weighted empirical processes in dynamic nonlinear models
por: Koul, Hira L
Publicado: (2002)

Disability Weights for Cancers in Korea
por: Choi, Kyu Sik, et al.
Publicado: (2013)

Castration
por: Pugh, T. J.
Publicado: (1897)

Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Disability Weights and Years Lived with Disability of Depression with and Without Suicidality
por: Pranjic, Nurka, et al.
Publicado: (2023)

Malnutrition management in oncology: An expert view on controversial issues and future perspectives
por: Bossi, Paolo, et al.
Publicado: (2022)

Non-communicable diseases: mapping research funding organisations, funding mechanisms and research practices in Italy and Germany
por: Stephani, Victor, et al.
Publicado: (2017)

Harnessing Digital Health Technologies During and After the COVID-19 Pandemic: Context Matters
por: Petracca, Francesco, et al.
Publicado: (2020)

Development features and study characteristics of mobile health apps in the management of chronic conditions: a systematic review of randomised trials
por: Cucciniello, Maria, et al.
Publicado: (2021)

Commentary: Nothing but a toothbrush for beginning the reduction of the postoperative costs in thoracic surgery
por: Bertolaccini, Luca, et al.
Publicado: (2022)

Recommendations for developing a lifecycle, multidimensional assessment framework for mobile medical apps
por: Tarricone, Rosanna, et al.
Publicado: (2022)

Value-based healthcare: Il nuovo approccio di AIFA alla determinazione multidimensionale del valore
por: Ciani, Oriana, et al.
Publicado: (2020)

Evaluating Barriers and Facilitators to the Uptake of mHealth Apps in Cancer Care Using the Consolidated Framework for Implementation Research: Scoping Literature Review
por: Ardito, Vittoria, et al.
Publicado: (2023)

The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022
por: Meregaglia, Michela, et al.
Publicado: (2023)

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study
por: Verzoni, Elena, et al.
Publicado: (2016)

The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis
por: Borsoi, Ludovica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ouhtmgft7d26ljhtaarkof0o1d